On 12th September, we met with members of our new Patient and Public Advisory Group to help shape the Unit’s research direction and plans.  The Advisory Group was made up of people with lived experience of a range of neurological and psychiatric conditions, as patients and carers.  The meeting started with a presentation by Unit Director Professor Peter Magill to familiarise the Group members with the Unit’s composition, achievements, and research vision.  This was followed by a lively discussion and Q & A session, moderated by the Unit’s Patient and Public Involvement Lead Dr. Melanie Fleming.  A variety of topics were discussed, ranging from patient needs to research priorities and on to emerging neurotechnology options for therapy.

Professor Magill commented, “We are committed to involving the public in our research. This first meeting of our new Patient and Public Advisory Group was fantastic. The conversations were open and free-flowing, and we are grateful for the Group’s insights. They will help us ensure that our research addresses important questions in the right ways to give greatest impact.”

Dr. Fleming added, “We are delighted with the hugely enthusiastic response to the summer call to join our Advisory Group. This meeting was a great opportunity to get advice and reflect on some key issues. We look forward to working with our public partners again soon.”